A field of growing interest in environmental health is that of lead speciation, the study of the various chemical forms of lead. Different lead compounds have different solubilities, which in turn affect bioavailability. Descriptions of lead exposure such as concentrations in air or settled dust are telling quantities, but can only relate part of the story. A variety of biological and geochemical influences will determine how much lead ultimately reaches the blood and becomes available to exert toxic effects. Previous studies have identified the major lead-bearing constituents associated with lead smelting procedures (1,2) and examined the role of speciation and particle size in solubility (3). In the current research article, Spear et al. investigate the geochemical factors of lead speciation and particle size, and their potential role in the bioavailability of lead from bulk and airborne smelter dusts.
The authors present results from a primary lead smelter. Dust samples were obtained from a variety of locations representing different stages of processing. Quantities of bulk dust were taken directly from surface areas within the smelter. Airborne dust was sampled with an apparatus that simulates intake by the human respiratory system. Samples were subjected to X-ray diffraction to identify the leaded compounds associated with the smelter dust. A chemical extraction method was applied to examine the relative solubilities of the dusts. The important characteristics of this study are therefore its abilities to comment on lead speciation and particle size over a range of locations in a lead smelter and to infer how these factors may influence human health.
From X-ray diffraction results, the smelter dust mineralogy is reported to be heavily influenced by lead sulfide. Dusts sampled in the processing areas of the plant reveal proportions of sulfates and complex oxides. The abundance of lead sulfide throughout the smelter is reflected in chemical extraction results from the bulk dust samples, which generally display low solubilities. Bulk dusts from furnace locations tend to be more soluble than those that accumulate near ore storage areas. This locational trend is reinforced by airborne dust results, which are probably more indicative of direct worker exposure. The air sampler allowed dust to also be examined by partide size. Fine partides of leaded dust are more commonly observed in furnace areas than in storage or sinter locations. Regardless of mineralogy, finer particles are reported to be more soluble. Coupled with the intrinsic solubility of the lead sulfates and oxides found near furnace processes, these findings have important implications for the relative health hazards associated with smelter furnace areas.
Lead speciation, particle size, and bioavailability are allfactors that may influence human health and that warrant continued investigation.
The Spear et al. article offers further evidence that a complete knowledge of workplace exposure to lead requires more information than simply the concentration in inhaled or ingested media. This is also true of studies of environmental lead. Significantly, environmentally exposed populations do not normally benefit from the regular blood lead monitoring associated with employment in the lead industries. Geochemical issues such as those examined in this article have complicated efforts to model indices of environmental lead exposure, absorption, and toxicity (4). Lead speciation, particle size, and bioavailability are all factors that may influence human health and that warrant investigation in the future. Although studies of this nature were carried out a few decades ago, recent advances in sampling and analytical techniques (some made by Pleil himself) have allowed the authors to follow the blood and breath decay curves for a longer period and with greater precision than before. The results are interesting and a bit puzzling. Before we explore these results, however, it is desirable to place this study in some perspective. The basic reason for being interested in the breath/blood relationship for some scores or hundreds of volatile organic compounds (VOCs) is that such knowledge would allow us to substitute a noninvasive, nonthreatening breath measurement for the more difficult, generally less precise, and harder to obtain blood sample. Thus, a number of authors have attempted to determine the blood/breath partition coefficient, which is the ratio of the arterial blood concentration to the concentration in exhaled alveolar breath. But there are difficulties in such measurements. We normally measure venous blood, not arterial, and it is not a simple matter to collect alveolar breath. These difficulties in making a direct measurement have forced investigators to estimate partition coefficients by indirect means, using in vitro methods for the most part.
Once the partition coefficient P is known, it is possible using physiologically based pharmacokinetic (PBPK) models such as that of Ramsey and Anderson (1) 
